Job Description

Company Overview

1910 Genetics is a Series A stage biotechnology company that is pioneering a novel Input-Transform-Output (ITO™) platform as the first ever horizontal AI infrastructure for drug discovery.

In a crowded space with hundreds of AI drug discovery companies, 1910’s ITO™ platform is differentiated by:

• Modality agnostic drug discovery: our platform is capable of designing both small molecule and large molecule therapeutics across all disease areas, with an initial focus on neuroscience, oncology, and autoimmune diseases.
• Proprietary massive multimodal data, which overcomes the data scarcity problem that prevents frontier AI models from being utilized for drug discovery.
• Multi-AI agent systems that include a robust collection of frontier AI/ML models, each of which works in a task-oriented manner to achieve the multi-parameter optimization problem of drug discovery and development.
• A state-of-the-art (SOTA) fully-automated, high thr...